Original language | English |
---|---|
Pages (from-to) | 1665-1669 |
Number of pages | 5 |
Journal | Journal of Allergy and Clinical Immunology |
Volume | 142 |
Issue number | 5 |
DOIs | |
State | Published - Nov 2018 |
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations
Lisa R. Forbes, Tiphanie P. Vogel, Megan A. Cooper, Johana Castro-Wagner, Edith Schussler, Katja G. Weinacht, Ashley S. Plant, Helen C. Su, Eric J. Allenspach, Mary Slatter, Mario Abinun, Desa Lilic, Charlotte Cunningham-Rundles, Olive Eckstein, Peter Olbrich, R. Paul Guillerman, Niraj C. Patel, Yesim Y. Demirdag, Christa Zerbe, Alexandra F. Freeman
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- COVID-19 Researchers
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Division of Rheumatology
- Rheumatic Diseases Research Resource-Based Center
- DBBS - Human and Statistical Genetics
- DBBS - Immunology
Research output: Contribution to journal › Article › peer-review
219
Scopus
citations